BioNTech SE (BNTX) has announced that its co-founders, Uğur Şahin and Özlem Türeci, will be stepping down to establish a new company focused on mRNA technology. BioNTech SE will retain a minority stake in the new enterprise and will provide certain technology licenses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments